Leukotriene receptor antagonists: A good choice in the treatment of premenstrual asthma?

Journal of Asthma

Volumn 45, Issue 2, 2008, Pages 95-99

  Pasaoglu, Gulden ^a   Mungan, Dilsad ^b   Abadoglu, Oznur ^c   Misirligil, Zeynep ^b  

^a Acibadem Health Care ^*  (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Department of Geology   (Turkey)

Author keywords

Leukotriene receptor antagonist; Premenstrual asthma; Therapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; ESTROGEN; FLUTICASONE PROPIONATE; FOLLITROPIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LUTEINIZING HORMONE; MONTELUKAST; PLACEBO; PROGESTERONE; STEROID;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; CHEST TIGHTNESS; CLINICAL ARTICLE; COUGHING; DEMOGRAPHY; DISEASE DURATION; DISEASE EXACERBATION; DRUG CHOICE; DRUG EFFICACY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; PEAK EXPIRATORY FLOW; PREMENSTRUAL ASTHMA; PROGESTERONE BLOOD LEVEL; STATISTICAL ANALYSIS; SYMPTOM; WHEEZING;

ACETATES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LEUKOTRIENE ANTAGONISTS; LUTEINIZING HORMONE; MENSTRUATION; MIDDLE AGED; PREMENSTRUAL SYNDROME; PROGESTERONE; QUINOLINES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 40949109384     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701751799     Document Type: Article

References (33)

1. Vrieze A, Posthma DS, Kersjens HAM. Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol 2003;112: 271-282.
2. Rees L. An aetiological study of premenstrual asthma. J Psychosomatic Res 1963;7:191-197.
3. Gibbs CJ, Coutts H, Lock R, et al. Premenstrual exacerbation of asthma. Thorax 1984;39:833-836.
4. Eliasson O, Scherzer HH, DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986;77:87-94.
5. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981;75:306-308.
6. Juniper EF, Kline PA, Roberts RS, et al. Airway responsiveness to methacholine during the natural menstrual cycle and the effect of oral contraceptives. Am Rev Respir Dis 1987;135:1039-1042.
7. Weinmann GG, Zacur H, Fish JE. Absence of changes in airway responsiveness during the menstrual cycle. J Allergy Clin Immunol 1987;79:634-638.
8. Pauli BD, Reid RL, Munt PW, et al. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989;140:358-362.
9. Nakasato H, Ohrui T, Sekizawa K, Matsui T, Yamaya M, Tamura G, et al. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist. J Allergy Clin Immunol 1999;104:585-588.
10. Rees MCP, Di Marzo V, Tippins JR, et al. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. J Endocrinol 1987;113:291. Abstract.
11. 4- and prostacyclinebinding sites in nonpregnant human uterine tissue. J Clin Endocrinol Metab 1988;66:76. Abstract.
12. 4: A potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 1982;217:841. Abstract.
13. Carraher R, Hahn DQ, Ritchie DM, et al. Involvement of lipoxygenase products in myometrial contractions. Prostaglandins 1983;26:23. Abstract
14. Perrin B, Bousquet J, Michel FB, Godard P, Jesuran M, Monabeka H, et al. Severe premenstrual asthma [letter]. Lancet 1988;2:843-844.
15. Morris D. Severe premenstrual asthma [letter]. Lancet 1988;2:843-844.
16. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996;156:1837-1840. Abstract.
17. Tan KS, McFarlane LC, Lipworth BJ. Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients. Thorax 1997;52:608-611.
18. Dean N, Sadat A, Nunnery S, et al. Montelukast provides supperior efficacy for perimenstrual asthma exacerbations not controlled by inhaled steroids. Chest 2001;120:208S.
19. Global strategy for asthma management and prevention. IN N.H. National Institute of Health, National Heart, Lung, and Blood Institute. 2002 Revised 2005. NHLBI/WHO Workshop report. NIH Publication 02-3659.
20. Vankrieken L, Van der Horst FAL, Castracane VD, et al. An international multicenter reference range study of normal menstrual cycles using IMMULITE reproductive hormone assays [abstract 322]. Clin Chem 1999;45(S6):A92. Full presentation available at DP2c's Web site, www.dpcweb.com, under Technical Documents, scientific Posters.
21. Nigam S, Benedetto C, Zonca M, et al. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 1991;4:137. Abstract
22. 4 in adolescents with dysmenorrhea. J Adolesc Health 2000;27:151. Abstract
23. Abu JI, Konje JC. Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhea and endometriosis. Hum Reprod Update 2000;6:200. Abstract
24. Shames RS, Heilbron DC, Janson SL, Kishiyama JL, Au DS, Adelman DC. Clinical differences among women with and without self-reported perimenstrual asthma. Ann Allergy Asthma Immunol 1998;81:65-72.
25. Juniper EF, Kline PA, Roberts RS, Hargreave FE, Daniel EE. Airway responsiveness to methacholine during the natural menstrual cycle and the effect of oral contraceptives. Am Rev Respir Dis 1987;135:1039-1042.
26. Weinmann GG, Zacur H, Fish JE. Absence of changes in airway responsiveness during the menstrual cycle. J Allergy Clin Immunol 1987;79:634-638.
27. Pauli BD, Reid RL, Munt PW, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989;140:358-362.
28. Rubio RL, Gago RB, Almirall CJJ, Bell HL, Fernandez FL. Comparative study of progesterone, estradiol and cortisol concentrations in asthmatic and non-asthmatic women. Allergol Immunopathol (Madr) 1988;16:263-266. Abstract
29. Chandler MH, Schuldheisz S, Philips BA, Muse KN. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary functions, and beta 2-receptors. Pharmacotherapy 1997;17:224-234. Citation.
30. Ensom MH, Chong G, Beaudin B, Bai TR. Estradiol in severe asthma with premenstrual worsening. Ann Pharmacother. 2003;37:1610-1613.
31. Murray RD, New JP, Barber PV, Shalet SM. Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma. Eur Respir J 1999;14:966-967.
32. Blumenfeld Z, Bentur L, Yoffe N, Alroy G, Rubin AH. Menstrual asthma: use of a gonadotropin-releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma. Fertil Steril 1994;62:197-200.
33. Pride SM, Yuen BH. Relief of asthma in two patients receiving danazol for endometriosis. CMAJ 1984;131:763-764.